Ann: VitroGro Sales Planned to Start in June 2012, page-56

re: Ann: VitroGro Sales Planned to Start in J... Paradigmshift,

As a shareholder in both TIS and ACR, I think the TIS deal with its partners is much better for TIS than the ACR deal. ACR did receive sizable up-front payments from its partner, but the cost of that is in getting very little in royalties in the first couple of years of sales, and then only increased once sales reach certain levels.

TIS does not have this limitation, and will benefit with a healthy proportion of sales revenues right from the start. So if anything, the share price trajectory could be quite different to that of ACR.